Pharmacology & ToxicologybioRxiv
ELQ-331 as a prototype for extremely durable chemoprotection against malaria
M. J. Smilkstein, S. Pou, A. Krollenbrock…·M. K. Riscoe
This paper evaluates ELQ-331 as a long-acting injectable chemoprotective agent against malaria, showing it provides durable protection in mice for up to 4.5 months.
DOI 10.1186/s12936-019-2921-9